4//SEC Filing
Ladone Mary Kay 4
Accession 0001578563-23-000051
CIK 0001665988other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:34 PM ET
Size
7.0 KB
Accession
0001578563-23-000051
Insider Transaction Report
Form 4
Ladone Mary Kay
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2023-06-16+1,813→ 20,274 total - Exercise/Conversion
Restricted Stock Units
2023-06-16−1,813→ 1,814 total→ Class A Common Stock (1,813 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- [F2]1,813 RSUs vested on June 16, 2023. The remaining 1,814 RSUs shall vest and become exercisable on June 16, 2024, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0001760737
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 5:34 PM ET
- Size
- 7.0 KB